dr. ellis discusses the cell-proliferation marker ki67
Published 13 years ago • 2.9K plays • Length 0:50Download video MP4
Download video MP3
Similar videos
-
1:52
dr. ellis discusses ki67 as a treatment monitoring biomarker
-
0:55
dr. ellis on measuring endocrine therapy efficacy with ki67
-
1:32
dr. ellis discusses genome forward breast cancer treatment
-
2:31
ki67, what is it and why is it controversial?
-
3:53
ki-67: explained!!! #medschooldiscussion
-
8:21
cancer metastasis in the bones - all symptoms
-
1:31:14
evolving therapeutic strategies for psoriatic diseases: not all il-23s are created similar - part 2
-
6:54
سؤال ع السريع: يعنى ki67 ويفرق فى ايه القيمه بتاعته 🙄🤔 هل فعلا اكتر من 30% يبقي خطر 😳
-
0:59
dr. ellis discusses the future of the pi3-kinase pathway
-
3:17
dr. goncalves discusses the development of a standardized ki-67 assay
-
1:32
dr. ellis discusses the falcon trial
-
1:12
dr. matthew ellis on heterogeneity impacting biomarker efficacy
-
2:47
the value of mipi and ki-67 in mantle cell lymphoma
-
1:12
the use of ki-67, a proliferation marker, for guiding treatment decisions in breast cancer patients
-
1:19
dr. nielsen on the pros and cons of the ki67 assay in breast cancer
-
1:00
dr. ellis considers the use of biosimilars in oncology
-
0:58
dr. ellis on anticipated er /her2- breast cancer paradigms
-
2:52
ki67 helps chromosomes keep their distance
-
1:21
the use of the ki-67 in deciding which patients with hr breast cancer can safely avoid chemotherapy
-
1:55
dr. matthew ellis on the future of tcga
-
4:15
choosing therapy for hr metastatic breast cancer
-
1:33
dr. mctiernan on biomarkers associated with poor prognosis in breast cancer